Citation Impact
Citing Papers
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients.
1989
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow
2017 StandoutNobel
Pirarubicin-induced Myocardial Damage in Elderly Patients with Non-Hodgkin's Lymphoma.
1998
The Clinical Significance of CD10 Antigen Expression in Diffuse Large B-Cell Lymphoma
2001
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
2010
Features of the dendritic cell lineage
2010 StandoutNobel
Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia
1992
Global Cancer Statistics, 2002
2005 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation
2006
Reactivation of and Primary Infection with Human Herpesvirus 8 among Solid‐Organ Transplant Recipients
2002
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Induction of a TRAIL mediated suicide program by interferon alpha in primary effusion lymphoma
2001
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Type I interferons in infectious disease
2015 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
2011 StandoutNobel
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Angiogenesis in health and disease
2003 Standout
Skin Cancers after Organ Transplantation
2003 Standout
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
Harnessing human dendritic cell subsets for medicine
2010
Utility of positron emission tomography scans in mantle cell lymphoma
2011
Putting tumours in context
2001 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Staying alive: regulation of plasma cell survival
2011
Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins
2008
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
RISK FACTORS FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC KIDNEY TRANSPLANTATION: A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY (NAPRTCS)1
2001
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Infectious agents and lymphoma development: molecular and clinical aspects
2009
CD28 and CTLA‐4 coreceptor expression and signal transduction
2009
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
The DNA methylome
2010
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma
1993
Malignant histiocytosis of the intestine
1978
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group
1982
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS
1974
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
Gluten, major histocompatibility complex, and the small intestine
1992 Standout
Histological Evaluation of Thyroid Carcinomas: Reproducibility of the «Who» Classification
1993
Attempts to demonstrate virus‐specific sequences in human tumors. IV. EB viral DNA in European burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis
1976 StandoutNobel
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis
1999
Criteria for the cytologic subclassification of follicular lymphomas: A Proposed alternative method
1983
Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma
2002
Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.
1986
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
PTP1B is a negative regulator of interleukin 4–induced STAT6 signaling
2008
Twenty years of MOPP therapy for Hodgkin's disease.
1986
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Frequencies and patterns of bone marrow involvement in non‐hodgkin lymphomas: Observations on the value of bilateral biopsies
1977
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Cancer Genome Landscapes
2013 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Pathogenic Long-Lived Plasma Cells and Their Survival Niches in Autoimmunity, Malignancy, and Allergy
2012
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
2011
Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with an intensive epirubicin-containing regimen
1993
Involvement of CD44-hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukemia
2000
Mandatory second opinion surgical pathology at a large referral hospital
1999
Risk patterns of Hodgkin's disease in Los Angeles vary by cell type.
1993
Histologic assessment of lymph nodes in mycosis fungoides/sézary syndrome (cutaneous T-cell lymphoma): Clinical correlations and prognostic import of a new classification system
1985
Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells
2011
Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane
2008
Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells
2000
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
2008
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
2012 StandoutNobel
Differentiation of Effector CD4 T Cell Populations
2010 Standout
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of Gerald E. Byrne being referenced
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP
2008
Post‐transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era
1997
Ocular adnexal lymphoma: no evidence for bacterial DNA associated with lymphoma pathogenesis
2008
High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma
2009
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
2007
Optimization of RNA Extraction From Formalin-fixed, Paraffin-embedded Lymphoid Tissues
2007
Treatment of AIDS-Related Primary Central Nervous System Lymphoma with Zidovudine, Ganciclovir, and Interleukin 2
1999
Malignant histiocytosis: Complete remission with combination chemotherapy
1976
Hairy cell leukemia (leukemic reticuloendotheliosis).I. A clinical pathologic study of 21 patients
1974
The phenotypic diversity of peripheral T-cell lymphomas: The Southeastern Cancer Study Group experience
1986
Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.
1985
Subcategories of histiocytic lymphoma: Associations with survival and reproducibility of classification. The southeastern cancer study group experience
1981
CD28-mediated regulation of multiple myeloma cell proliferation and survival
2007
Histopathologic review of lymphoma cases from the southwest oncology group
1977
Bone marrow involvement in non-Hodgkin's lymphoma. Implications for staging and therapy
1976
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma
2006
Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group study
1983
Involvement of the central nervous system by non-Hodgkin's lymphoma.The southwest oncology group experience
1979
CD28 Expressed on Malignant Plasma Cells Induces a Prosurvival and Immunosuppressive Microenvironment
2011
LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab
2007
Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-bleomycin in the management of advanced Hodgkin-s disease a southwest oncology group study
1983
Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group study
1979
Pathology Panel for Lymphoma Clinical Studies: A Comprehensive Analysis of Cases Accumulated Since Its Inception<xref ref-type="fn" rid="FN2">2</xref>
1982
Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci
2005
Human Herpesvirus Type 8 DNA Sequences in Cell-Free Plasma and Mononuclear Cells of Kaposi's Sarcoma Patients
1996